Trial Profile
A real-life study analysing the treatment with rivaroxaban in Italian patients with venous thromboembolism
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Sep 2018
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Venous thromboembolism
- Focus Therapeutic Use
- 11 Sep 2018 New trial record